Achieve Life Sciences, Inc. (ACHV)
NASDAQ: ACHV · Real-Time Price · USD
3.170
-0.050 (-1.55%)
Feb 21, 2025, 4:00 PM EST - Market closed
Achieve Life Sciences Employees
Achieve Life Sciences had 22 employees as of December 31, 2023. The number of employees increased by 2 or 10.00% compared to the previous year.
Employees
22
Change (1Y)
2
Growth (1Y)
10.00%
Revenue / Employee
n/a
Profits / Employee
-$1,497,409
Market Cap
109.02M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 440,000 |
| Johnson & Johnson | 131,900 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 72,000 |
ACHV News
- 11 days ago - Achieve Life Sciences to Present at the Oppenheimer Healthcare Life Sciences Conference - GlobeNewsWire
- 12 days ago - Achieve Life Sciences Announces Positive Outcome of Second Data Safety Monitoring Committee Review for the ORCA-OL Clinical Trial - GlobeNewsWire
- 6 weeks ago - Achieve Life Sciences Appoints Dr. Kristen Slaoui and Nancy Phelan to its Board of Directors - GlobeNewsWire
- 6 weeks ago - Achieve Life Sciences Announces Critical Milestone Successfully Reached in ORCA-OL Cytisinicline Clinical Trial Required for NDA Submission - GlobeNewsWire
- 6 weeks ago - Achieve Life Sciences to Host Meetings During the J.P. Morgan Healthcare Conference Week - GlobeNewsWire
- 2 months ago - Achieve Life Sciences Appoints Mark Oki as Chief Financial Officer - GlobeNewsWire
- 2 months ago - Achieve Life Sciences to Advance First Vaping Cessation Therapy After Successful End-of-Phase 2 Meeting with FDA - GlobeNewsWire
- 3 months ago - Smoking Cessation Pipeline Insight 2024, with Focus on Emerging Drugs Cytisinicline (Achieve Life Sciences), EMB-001(Embera Pharmaceuticals) and SBP-9330 (Camino Pharma) - GlobeNewsWire